Why Nelson Peltz Bought Lazard $LAZ

TRIAN PARTNERSHere is a 39 page presentation by Nelson Peltz’s Trian Fund Management explaining why they bought Lazard (LAZ):

Trian-Management Lazard-Presentation-2012

Peltz disclosed this holding through an amended 13F filing. According to recent academic research, these stock picks have an annual alpha of nearly 10 percent.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!